A synergistic pharmaceutical combination for the prevention...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/455 (2006.01) A61K 31/155 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2452558

The invention refers to a synergistic pharmaceutical combination which comprises (a) a first pharmaceutical composition containing an antidiabetic or anti-hyperlipidemic active agent and one or more conventional carrier(s), and (b) a second pharmaceutical composition containing a hydroximic acid derivative of the formula I and one or more conventional carrier(s). The pharmaceutical combination is suitable for the prevention or treatment of , among others, diabetes mellitus.

L'invention concerne une combinaison pharmaceutique synergique qui renferme : (a) une première composition pharmaceutique qui contient un agent actif antidiabétique ou hypolipidémiant, et un ou plusieurs excipient(s) classique(s) ; et (b) une deuxième composition pharmaceutique qui contient un dérivé d'acide hydroximique représenté par la formule I, et un ou plusieurs excipient(s) classique(s). Cette combinaison pharmaceutique convient pour prévenir ou traiter, entre autres, le diabète sucré.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A synergistic pharmaceutical combination for the prevention... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A synergistic pharmaceutical combination for the prevention..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A synergistic pharmaceutical combination for the prevention... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1678338

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.